Model Information:
Transitional cell carcinoma of the bladder; poorly differentiated tumor involving most of the sampled tissue with malignant cells present in cytologic preparations.
Request a Custom Quote for XB4009 Xenograft ModelSummary:
| Category | Parameter | Model Detail (XB4009) |
| Identity | Model ID | XB4009 |
| Cancer Type | Bladder Cancer | |
| Model Type | PDX (Patient-Derived Xenograft) | |
| Clinical Background | Patient Age | 77 |
| Patient Gender | Male | |
| Ethnicity | N/A | |
| Diagnosis | Poorly Differentiated Transitional Cell Carcinoma | |
| Stage | High-grade / Advanced | |
| Sample Site | Bladder Tissue (Cytology positive) | |
| Genomics & Biomarkers | Primary Driver | TP53 / MDM2 Amplification |
| Cytogenetics | N/A | |
| WES (Whole Exome) | N/A | |
| RNA-Seq | N/A | |
| CNV Profile | N/A | |
| Mutational Load | N/A | |
| Characterization | Surface Markers | GATA3 (Variable), CK7+, Ki-67 (High) |
| Host Strain | NSG (NOD scid gamma) | |
| Inoculation Route | Subcutaneous | |
| Growth Kinetic | N/A | |
| Pharmacology | SoC Response | N/A |
| Immune Profiling | N/A |
Growth Characteristics:
